Bristol Historical Income Statement

BMY Stock  USD 53.25  0.70  1.33%   
Historical analysis of Bristol Myers income statement accounts such as Interest Expense of 1.2 B, Selling General Administrative of 8.4 B or Total Revenue of 47.3 B can show how well Bristol Myers Squibb performed in making a profits. Evaluating Bristol Myers income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bristol Myers's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Bristol-Myers Squibb latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bristol-Myers Squibb is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

About Bristol Income Statement Analysis

Bristol-Myers Squibb Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bristol Myers shareholders. The income statement also shows Bristol investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bristol Myers Income Statement Chart

Bristol Myers Squibb Income Statement is one of the three primary financial statements used for reporting Bristol's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bristol-Myers Squibb revenue and expense. Bristol Myers Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bristol Myers' Net Income is fairly stable compared to the past year. Research Development is likely to rise to about 9.8 B in 2024, whereas EBIT is likely to drop slightly above 5.1 B in 2024.

Total Revenue

Total revenue comprises all receipts Bristol-Myers Squibb generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bristol Myers Squibb minus its cost of goods sold. It is profit before Bristol Myers operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bristol-Myers Squibb. It is also known as Bristol Myers overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Bristol Myers' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bristol-Myers Squibb current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
At this time, Bristol Myers' Net Income is fairly stable compared to the past year. Research Development is likely to rise to about 9.8 B in 2024, whereas EBIT is likely to drop slightly above 5.1 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit36.4B36.0B34.3B36.0B
Total Revenue46.4B46.2B45.0B47.3B

Bristol Myers income statement Correlations

0.970.870.970.970.970.810.710.970.790.980.05-0.450.19-0.020.890.84-0.28-0.540.10.38-0.11-0.01-0.970.770.98
0.970.860.970.960.980.740.710.940.860.98-0.01-0.530.110.040.930.86-0.32-0.450.040.44-0.120.06-1.00.680.97
0.870.860.860.850.840.770.690.870.740.830.12-0.390.23-0.020.740.57-0.11-0.490.240.08-0.15-0.1-0.890.710.85
0.970.970.861.00.990.840.80.980.850.980.17-0.380.270.070.940.85-0.24-0.530.180.47-0.160.07-0.960.770.94
0.970.960.851.00.980.850.810.990.830.980.21-0.350.310.040.930.85-0.24-0.530.210.46-0.180.04-0.950.790.94
0.970.980.840.990.980.780.730.960.861.00.04-0.480.150.080.960.88-0.31-0.50.040.5-0.080.1-0.970.720.95
0.810.740.770.840.850.780.690.880.550.770.430.070.61-0.140.680.66-0.09-0.820.540.34-0.42-0.2-0.730.920.71
0.710.710.690.80.810.730.690.830.810.720.58-0.150.460.210.70.55-0.01-0.170.390.23-0.140.15-0.70.60.74
0.970.940.870.980.990.960.880.830.80.960.26-0.310.360.040.880.8-0.2-0.550.270.37-0.170.02-0.940.810.93
0.790.860.740.850.830.860.550.810.80.840.06-0.58-0.030.280.860.7-0.21-0.11-0.090.40.040.29-0.850.460.86
0.980.980.830.980.981.00.770.720.960.840.03-0.470.150.050.960.89-0.33-0.490.040.5-0.080.08-0.970.720.96
0.05-0.010.120.170.210.040.430.580.260.060.030.690.9-0.010.010.010.12-0.150.880.02-0.48-0.110.020.410.01
-0.45-0.53-0.39-0.38-0.35-0.480.07-0.15-0.31-0.58-0.470.690.72-0.17-0.47-0.330.03-0.230.72-0.04-0.46-0.20.540.11-0.54
0.190.110.230.270.310.150.610.460.36-0.030.150.90.72-0.320.080.19-0.02-0.470.960.16-0.66-0.37-0.090.610.09
-0.020.04-0.020.070.040.08-0.140.210.040.280.05-0.01-0.17-0.320.2-0.080.010.26-0.33-0.060.550.93-0.04-0.210.02
0.890.930.740.940.930.960.680.70.880.860.960.01-0.470.080.20.88-0.38-0.41-0.050.60.010.25-0.90.620.88
0.840.860.570.850.850.880.660.550.80.70.890.01-0.330.19-0.080.88-0.61-0.490.030.81-0.190.09-0.830.680.81
-0.28-0.32-0.11-0.24-0.24-0.31-0.09-0.01-0.2-0.21-0.330.120.03-0.020.01-0.38-0.610.160.05-0.670.02-0.250.32-0.25-0.29
-0.54-0.45-0.49-0.53-0.53-0.5-0.82-0.17-0.55-0.11-0.49-0.15-0.23-0.470.26-0.41-0.490.16-0.43-0.320.40.280.44-0.78-0.37
0.10.040.240.180.210.040.540.390.27-0.090.040.880.720.96-0.33-0.050.030.05-0.43-0.01-0.69-0.4-0.040.540.01
0.380.440.080.470.460.50.340.230.370.40.50.02-0.040.16-0.060.60.81-0.67-0.32-0.01-0.220.18-0.380.370.34
-0.11-0.12-0.15-0.16-0.18-0.08-0.42-0.14-0.170.04-0.08-0.48-0.46-0.660.550.01-0.190.020.4-0.69-0.220.540.09-0.51-0.03
-0.010.06-0.10.070.040.1-0.20.150.020.290.08-0.11-0.2-0.370.930.250.09-0.250.28-0.40.180.54-0.06-0.220.04
-0.97-1.0-0.89-0.96-0.95-0.97-0.73-0.7-0.94-0.85-0.970.020.54-0.09-0.04-0.9-0.830.320.44-0.04-0.380.09-0.06-0.67-0.97
0.770.680.710.770.790.720.920.60.810.460.720.410.110.61-0.210.620.68-0.25-0.780.540.37-0.51-0.22-0.670.67
0.980.970.850.940.940.950.710.740.930.860.960.01-0.540.090.020.880.81-0.29-0.370.010.34-0.030.04-0.970.67
Click cells to compare fundamentals

Bristol Myers Account Relationship Matchups

Bristol Myers income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.1B9.7B10.0B9.6B9.8B10.2B
Interest Expense656M1.4B1.3B1.2B1.2B1.2B
Selling General Administrative4.9B7.7B7.7B7.8B8.0B8.4B
Total Revenue26.1B42.5B46.4B46.2B45.0B47.3B
Gross Profit18.1B30.7B36.4B36.0B34.3B36.0B
Other Operating Expenses20.2B40.3B37.8B37.1B36.8B38.7B
Operating Income5.5B5.1B10.2B10.3B17.2B18.1B
Ebit5.5B5.1B10.2B10.3B9.4B5.1B
Ebitda6.6B14.8B20.2B19.9B19.2B20.1B
Cost Of Revenue8.1B11.8B9.9B10.1B10.7B5.8B
Total Operating Expenses12.2B28.6B27.9B26.9B26.1B27.4B
Income Before Tax5.0B(6.9B)8.1B7.7B8.4B4.2B
Total Other Income Expense Net(489M)(12.0B)(2.1B)(2.6B)1.4B1.5B
Net Income3.4B(9.0B)7.0B6.3B8.0B8.4B
Income Tax Expense1.5B2.1B1.1B1.4B400M380M
Research Development6.1B11.1B10.2B9.5B9.3B9.8B
Selling And Marketing Expenses4.9B7.7B7.7B7.8B8.0B8.4B
Net Income Applicable To Common Shares3.4B(9.0B)7.0B6.3B5.7B6.0B
Minority Interest21M20M(20M)(18M)(16.2M)(15.4M)
Net Income From Continuing Ops6.5B(9.0B)7.0B6.3B8.3B8.7B
Non Operating Income Net Other(938M)2.3B720M(576M)(662.4M)(629.3M)
Tax Provision1.5B2.1B1.1B1.4B322M305.9M
Net Interest Income(656M)(1.4B)(1.3B)(1.2B)(1.1B)(1.2B)
Interest Income69M71M550M1.9B2.1B2.2B
Reconciled Depreciation1.7B10.4B10.0B9.6B9.8B6.8B

Pair Trading with Bristol Myers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol Myers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bristol Stock

  0.69MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bristol Stock

  0.7MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.6MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.56KA Kineta Inc Report 29th of March 2024 PairCorr
  0.56VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol Myers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol-Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol Myers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.